Changeflow GovPing Healthcare Capsule Inhaler for PDE4 Inhibitor for Respirat...
Routine Notice Added Draft

Capsule Inhaler for PDE4 Inhibitor for Respiratory Treatment

Favicon for changeflow.com USPTO Patent Applications - Medical Devices (A61M)
Published
Detected
Email

Summary

USPTO published patent application US20260090986A1 for a capsule inhaler for administering a PDE4 inhibitor for respiratory treatment, filed by CHIESI FARMACEUTICI S.P.A. The application claims a dry powder inhalation device with a pharmaceutical composition comprising micronized particles of a PDE4 inhibitor and a carrier. This is an informational publication of a pending patent application with no regulatory implications.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

The patent application US20260090986A1, published April 2, 2026, discloses a drug product comprising a single-dose dry powder inhalation device and a pharmaceutical composition filled in a capsule. The composition contains micronized particles of a PDE4 inhibitor compound and a carrier. The application also covers methods of treatment for respiratory diseases using this drug product.

This publication represents an early-stage intellectual property filing by CHIESI FARMACEUTICI S.P.A. and does not create any compliance obligations or regulatory requirements. The application remains pending and has not yet been granted. No action is required from regulated entities.

Archived snapshot

Apr 2, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

CAPSULE INHALER FOR THE ADMINISTRATION OF A PHOSPHODIESTERASE-4 INHIBITOR

Application US20260090986A1 Kind: A1 Apr 02, 2026

Assignee

CHIESI FARMACEUTICI S.P.A.

Inventors

Francesca BUTTINI, Giada VARACCA, Romina OSELLO

Abstract

The present invention relates to a drug product comprising a single-dose dry powder inhalation device and a pharmaceutical composition filled in a capsule, the pharmaceutical composition comprising micronized particles of the compound of formula (I) and a carrier. The present invention also relates to a drug product or a pharmaceutical composition for use for the treatment of a respiratory disease and to a method for the treatment of a respiratory disease.

CPC Classifications

A61K 9/0075 A61K 31/4425 A61M 15/0021 A61M 15/004 A61M 15/08

Filing Date

2023-09-21

Application No.

19112650

View original document →

Get daily alerts for USPTO Patent Applications - Medical Devices (A61M)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 2nd, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Draft
Change scope
Minor
Document ID
US20260090986A1

Who this affects

Applies to
Pharmaceutical companies Medical device makers
Industry sector
3254 Pharmaceutical Manufacturing 3345 Medical Device Manufacturing
Activity scope
Drug Delivery Device Pharmaceutical Manufacturing
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals Medical Devices

Get alerts for this source

We'll email you when USPTO Patent Applications - Medical Devices (A61M) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!